Skip to content
10-K

Annual Report

Kura Oncology, Inc. KURA

0001193125-26-092567

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 88.33M sh
Shares Diluted FY 2025 · Dec 31, 2025 87.68M sh
Shares Diluted FY 2025 · Dec 31, 2024 86.16M sh
Shares Diluted FY 2025 · Dec 31, 2023 73.23M sh
Capex FY 2025 · Dec 31, 2025 $6.64M
Capex FY 2025 · Dec 31, 2024 $472K
Capex FY 2025 · Dec 31, 2023 $168K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$64.06M
Operating Cash Flow FY 2025 · Dec 31, 2024 $134.32M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$124.82M
Long Term Debt FY 2025 · Dec 31, 2025 $9.71M
Long Term Debt FY 2025 · Dec 31, 2024 $6.92M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $2.61M
Cash And Equivalents FY 2025 · Dec 31, 2025 $149.1M
Cash And Equivalents FY 2025 · Dec 31, 2024 $224.46M
Stockholders Equity FY 2025 · Dec 31, 2025 $174.14M
Stockholders Equity FY 2025 · Dec 31, 2024 $413.64M
Stockholders Equity FY 2025 · Dec 31, 2023 $397.27M
Stockholders Equity FY 2025 · Dec 31, 2022 $420.28M
Current Liabilities FY 2025 · Dec 31, 2025 $116.97M
Current Liabilities FY 2025 · Dec 31, 2024 $78.71M
Total Liabilities FY 2025 · Dec 31, 2025 $564.23M
Total Liabilities FY 2025 · Dec 31, 2024 $346.52M
Current Assets FY 2025 · Dec 31, 2025 $708.66M
Current Assets FY 2025 · Dec 31, 2024 $744.83M
Total Assets FY 2025 · Dec 31, 2025 $738.36M
Total Assets FY 2025 · Dec 31, 2024 $760.16M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.18
Eps Diluted FY 2025 · Dec 31, 2024 −$2.02
Eps Diluted FY 2025 · Dec 31, 2023 −$2.08
Eps Basic FY 2025 · Dec 31, 2025 −$3.18
Eps Basic FY 2025 · Dec 31, 2024 −$2.02
Eps Basic FY 2025 · Dec 31, 2023 −$2.08
Sga Expense FY 2025 · Dec 31, 2025 $119.98M
Sga Expense FY 2025 · Dec 31, 2024 $77.11M
Sga Expense FY 2025 · Dec 31, 2023 $50.57M
Rd Expense FY 2025 · Dec 31, 2025 $251.07M
Rd Expense FY 2025 · Dec 31, 2024 $169.97M
Rd Expense FY 2025 · Dec 31, 2023 $115.24M
Net Income FY 2025 · Dec 31, 2025 −$278.67M
Net Income FY 2025 · Dec 31, 2024 −$173.98M
Net Income FY 2025 · Dec 31, 2023 −$152.63M
Operating Income FY 2025 · Dec 31, 2025 −$303.63M
Operating Income FY 2025 · Dec 31, 2024 −$193.2M
Operating Income FY 2025 · Dec 31, 2023 −$165.8M
Revenue FY 2025 · Dec 31, 2025 $67.48M
Revenue FY 2025 · Dec 31, 2024 $53.88M
Revenue FY 2025 · Dec 31, 2023 $0